Farmaceutica REMEDIA S A : 2023 Balance sheet – unconsolidated

31.12.2023

31.12.2022

Net turnover

15.379.933

18.307.055

Income from the sale of goods

11.370.803

15.084.967

Commercial discounts granted

0

0

Income from services provided and rents

4.009.129

3.222.088

Other operating income

5.573.817

2.874.500

OPERATING INCOME - TOTAL

20.953.750

21.181.555

Expenses with materials

9.998.633

13.608.407

Expenses regarding goods

9.402.741

13.058.243

Commercial discounts received

-19.909

-76.566

Expenses with raw materials and consumables

385.524

375.199

Other expenses with materials (inventory objects)

32.451

47.316

Energy and water expenses

197.826

204.215

Expenses with personnel

4.392.156

4.417.169

Salaries and allowances

3.538.249

3.502.561

Expenses with insurance and social protection

94.608

165.582

Other personnel expenses

759.299

749.026

Amortisations and provisions

4.073.840

2.716.674

Amortisations

4.073.390

2.717.999

Net provisions

0

-9.191

Losses from receivables

450

7.865

Other operating expenses

3.471.646

2.823.298

Expenses on external services

1.393.114

1.334.698

Expenses with other taxes, charges and assimilated payments

1.197.106

802.627

Other expenses

881.426

685.973

OPERATING EXPENSES - TOTAL

21.936.274

23.565.548

OPERATING RESULT

-982.525

-2.383.993

Financial income

5.413.254

5.321.320

Interest income

343.634

237.069

Income from exchange rate differences

1.314

4.424

Income from dividends

5.068.305

5.079.826

Advance payment discounts

0

0

Other financial income

0

0

Financial expenses

55.867

21.301

Expenses with interests leasing

53.571

0

Expenses due to exchange rate differences

2.296

21.301

Discounts received in advance

0

0

Other financial expenses

FINANCIAL RESULT

5.357.387

5.300.018

TOTAL INCOME

26.367.003

26.502.875

TOTAL EXPENSES

21.992.142

23.586.849

GROSS RESULT

4.374.862

2.916.026

Profit tax

0

0

TOTAL NET PROFIT of which distributable

4.374.862

2.916.026

Shareholders of the company

4.374.862

2.916.026

Minority interest

Other elements of comprehensive income

Revaluation of tangible assets

Tax related to other elements of comprehensive income

Minority interest

COMPREHENSIVE INCOME AFFERENT TO THE PERIOD - TOTAL of which attributable:

4.374.862

2.916.026

Shareholders of the company

4.374.862

2.916.026

Minority interest

Earnings per share (in Lei)

- basic

0,0458

0,0305

- diluted

0,0458

0,0305

31.12.2023

31.12.2022

ASSETS

Fixed assets

49.600.603

47.370.124

Tangible assets

26.658.751

23.487.049

Real estate investments

16.364.407

16.545.703

Operational leasing assets

667.684

Software licences

76.006

63.649

Pharmacy licences

178.255

689.200

Participations held in group companies

602.200

891.720

Participations held in companies outside the group

5.916

5.916

Deposits and guarantees paid

5.047.385

5.686.888

Current assets

15.001.185

14.704.786

Stocks

2.298.411

2.179.248

Trade receivables

4.260.102

3.085.858

Other receivables

459.956

542.286

Cash and cash equivalents

7.982.716

8.897.395

Accrued expenses

372.077

439.812

TOTAL ASSETS

64.973.864

62.514.723

EQUITIES AND DEBTS

Equities

52.856.662

52.977.439

Share capital

9.860.311

9.860.311

Share premiums

757.485

757.485

Reserves

40.426.106

39.419.786

Current result

4.374.862

2.916.026

Retained earnings

11.123

448.688

Retained earnings - retreatment

-312.229

-312.229

Profit distribution

0

0

Own shares

-2.260.996

-112.628

Long-term debts

4.894.215

3.175.842

Debts from long term leasing

646.142

Debts from operational leasing

Provisions

4.248.073

3.175.842

Debts with deferred income tax

7.222.987

6.361.443

Current debts

Bank loans

Debts from financial leasing

180.013

Suppliers and other similar debts

5.908.015

5.531.838

Provisions

Current tax debts

Other short-term debts

1.134.959

829.605

Total debts

12.117.202

9.537.284

TOTAL EQUITIES AND DEBTS

64.973.864

62.514.723